In-Vitro Toxicology Testing Market Size- By Method, By End User, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

In- Vitro Toxicology Testing Market Introduction and Overview

According to SPER Market Research, 'Global In-Vitro Toxicology Testing Market Size- By Method, By End Use, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Global In-Vitro Toxicology Testing Market is estimated to reach USD 34.76 billion by 2033 with a CAGR of 11.05%.

It is well acknowledged that leveraging market opportunities requires the creation of an integrated approach. The growing tendency of outsourcing toxicological assessment services is another factor that is expected to have a significant impact on this market's growth.

High-throughput and automated testing methods were quickly adopted in response to the pandemic in order to meet the increasing demand and lessen the dependency on manual operations. Increasingly, digital tools have been used for virtual consultations, distant cooperation, and data administration, which has improved research productivity and flexibility.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Method, By End Use, By Technology, By Application

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Abbott, Agilent Technologies, BioIVT, Bio-Rad Laboratories, Inc, Catalent, Inc, Charles River, Creative Bioarray, Evotec, Eurofins Scientific, GE Healthcare, Gentronix, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS SA, Thermo Fisher Scientific Inc.

Global In-Vitro Toxicology Testing Market Segmentation:

By Method: Based on the Method, Global In-Vitro Toxicology Testing Market is segmented as; Cellular Assay (Live Cells, fixed cells), Biochemical Assay, In-Silico, Ex-vivo.

By Technology: Based on the Technology, Global In-Vitro Toxicology Testing Market is segmented as; Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology.

By Application: Based on the Application, Global In-Vitro Toxicology Testing Market is segmented as; Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Product Code: HLCA2470

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global In-Vitro Toxicology Testing Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global In-Vitro Toxicology Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global In-Vitro Toxicology Testing Market

7. Global In-Vitro Toxicology Testing Market, By Method (USD Million) 2020-2033

7.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2020-2026
7.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2027-2033
7.3. Cellular Assay
- 7.3.1. Live Cells
- 7.3.2. Fixed Cells
7.4. Biochemical Assay
7.5. In-Silico
7.6. Ex-vivo

8. Global In-Vitro Toxicology Testing Market, By End Use (USD Million) 2020-2033

8.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2020-2026
8.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2027-2033
8.3. Pharmaceutical Industry
8.4. Cosmetics & Household Products
8.5. Academic Institutes and Research Laboratories
8.6. Diagnostics
8.7. Chemical Industry
8.8. Food Industry

9. Global In-Vitro Toxicology Testing Market, By Technology (USD Million) 2020-2033

9.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2027-2033
9.3. Cell Culture Technology
9.4. High Throughput Technology
9.5. Molecular Imaging
9.6. OMICS Technology

10. Global In-Vitro Toxicology Testing Market, By Application (USD Million) 2020-2033

10.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application, 2020-2026
10.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application 2027-2033
10.3. Systemic Toxicology
10.4. Dermal Toxicity
10.5. Endocrine Disruption
10.6. Ocular Toxicity
10.7. Other Applications

11. Global In-Vitro Toxicology Testing Market Forecast, 2020-2033 (USD Million)

11.1. Global In-Vitro Toxicology Testing Market Size and Market Share

12. Global In-Vitro Toxicology Testing Market, By Region, 2020-2033 (USD Million)

12.1. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2020-2026)
12.2. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2027-2033)
12.3. Asia-Pacific
- 12.3.1. Australia
- 12.3.2. China
- 12.3.3. India
- 12.3.4. Japan
- 12.3.5. South Korea
- 12.3.6. Rest of Asia-Pacific
12.4. Europe
- 12.4.1. France
- 12.4.2. Germany
- 12.4.3. Italy
- 12.4.4. Spain
- 12.4.5. United Kingdom
- 12.4.6. Rest of Europe
12.5. Middle East and Africa
- 12.5.1. Kingdom of Saudi Arabia
- 12.5.2. United Arab Emirates
- 12.5.3. Qatar
- 12.5.4. South Africa
- 12.5.5. Egypt
- 12.5.6. Morocco
- 12.5.7. Nigeria
- 12.5.8. Rest of Middle-East and Africa
12.6. North America
- 12.6.1. Canada
- 12.6.2. Mexico
- 12.6.3. United States
12.7. Latin America
- 12.7.1. Argentina
- 12.7.2. Brazil
- 12.7.3. Rest of Latin America

13. Company Profile

13.1. ABBOTT
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. AGILENT TECHNOLOGIES
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. BIO-RAD LABORATORIES, INC
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. CATALENT, INC
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. EUROFINS SCIENTIFIC
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. GE HEALTHCARE
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. MERCK KGAA
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. QUEST DIAGNOSTICS INCORPORATED
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. THERMO FISHER SCIENTIFIC INC
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Others